![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 1292-1298, March 2003
Department of Pharmacology, New York Medical College, Valhalla, New
York
Epoxyeicosatrienoic acids (EETs) are cytochrome P450-derived
metabolites of arachidonic acid that elicit vasodilation via activation
of K+ channels. They have been implicated as
endothelium-derived hyperpolarizing factors (EDHFs), mediating the
effect of some endothelium-dependent vasodilator agents such as
bradykinin in some vascular tissues. We reasoned that an agent that
increases the availability of free arachidonic acid should also elicit
cytochrome P450-dependent vasodilation that is associated with
increased release of EETs and attenuated by agents that inhibit the
synthesis or action of EETs. Thus, we used thimerosal as an inhibitor
of reacylation of arachidonic acid and determined the contribution of
prostaglandins, nitric oxide, and EETs to the vasodilator effect in the
isolated, perfused, preconstricted kidney of the rat. Thimerosal
elicited vasodilator responses that were unaffected by inhibition of
cyclooxygenase with indomethacin but were reduced by the further
inhibition of nitric oxide synthesis. The vasodilator activity that
remained after inhibition of cyclooxygenase and nitric oxide synthase
was reduced by inhibition of K+ channels with
tetraethylammonium and was associated with increased release of EETs
measured by gas chromatography-mass spectroscopy following hydrolysis
to the corresponding diols. Inhibition of cytochrome P450 with
miconazole or epoxygenase with
N-methylsulfonyl-6-(2-propargyloxyphenyl)hexamide reduced the nitric oxide- and prostaglandin-independent vasodilator effect of thimerosal and attenuated the increase in the release of
EETs. We conclude that thimerosal causes vasodilation of the isolated
perfused kidney via nitric oxide-dependent and -independent mechanisms.
The nitric oxide-independent component of the response involves
activation of K+ channels and is likely mediated by EETs,
possibly acting as EDHFs.
This article has been cited by other articles:
![]() |
A. Dhanasekaran, S. K. Gruenloh, J. N. Buonaccorsi, R. Zhang, G. J. Gross, J. R. Falck, P. K. Patel, E. R. Jacobs, and M. Medhora Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H724 - H735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, X. Wei, X. Xiao, R. Hui, J. W. Card, M. A. Carey, D. W. Wang, and D. C. Zeldin Arachidonic Acid Epoxygenase Metabolites Stimulate Endothelial Cell Growth and Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 522 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. El-Saadani A Scorpion Venom Peptide Fraction Induced Prostaglandin Biosynthesis in Guinea Pig Kidneys: Incorporation of 14C-Linoleic Acid J. Biochem., January 1, 2004; 135(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff 5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR Hypertension, October 1, 2003; 42(4): 548 - 554. [Abstract] [Full Text] [PDF] |
||||